# Therapeutic Relevance of Abnormal Airway Morphology in Asthma

> **NCT06970080** · PHASE4 · RECRUITING · sponsor: **McMaster University** · enrollment: 242 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Inhaled corticosteroid (ICS)
- **DRUG:** Oral Corticosteroid (OCS)

## Key facts

- **NCT ID:** NCT06970080
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-02
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 242 (ESTIMATED)
- **Last updated:** 2025-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06970080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06970080, "Therapeutic Relevance of Abnormal Airway Morphology in Asthma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06970080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*